Brayne, Carol

Improving access to psychological therapies and older people: Findings from the Eastern Region

Matthew Prina, A., Marioni, R. E., Hammond, G. C., Jones, P. B., Brayne, C., & Dening, T. (2014) · Behaviour Research and Therapy

Mental Health Treatment and AccessPsychotherapy Techniques and Applications

Cited by 37

Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial

Eggink, E., Hafdi, M., Hoevenaar-Blom, M. P., Song, M., Andrieu, S., Barnes, L. E., Birck, C., Brooks, R. L., Coley, N., Ford, E., et al. (2021) · BMJ Open

Mobile Health and mHealth ApplicationsDementia and Cognitive Impairment Research

Cited by 37

History of benzodiazepine prescriptions and risk of dementia: possible bias due to prevalent users and covariate measurement timing in a nested case-control study

Richardson, K., Mattishent, K., Loke, Y. K., Steel, N., Fox, C., Grossi, C. M., Bennett, K., Maidment, I., Boustani, M., Matthews, F. E., et al. (2019) · American Journal of Epidemiology

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 36

Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory)

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 35

A systematic review of the cost-effectiveness of community and population interventions to reduce the modifiable risk factors for dementia

Walsh, S., Brain, J., Mukadam, N., Anderson, R., Greene, L., Govia, I., Kuhn, I., Anstey, K. J., Knapp, M., Stephan, B. C. M., et al. (2022) · Maturitas

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 33

The incidence of Parkinson's disease in the North-East of England

Duncan, G. W., Khoo, T. K., Coleman, S. Y., Brayne, C., Yarnall, A. J., O'Brien, J. T., Barker, R. A., & Burn, D. J. (2014) · Age and Ageing

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 32

The Nairobi Declaration—reducing the burden of dementia in low- and middle-income countries (LMICs): declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs

Maestre, G., Carrillo, M., Kalaria, R., Acosta, D., Adams, L., Adoukonou, T., Akinwande, K., Akinyemi, J., Akinyemi, R., Akpa, O., et al. (2023) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchMental Health Treatment and Access

Cited by 31

Gene-Based Analysis in HRC Imputed Genome Wide Association Data Identifies Three Novel Genes For Alzheimer’s Disease

Baker, E., Sims, R., Leonenko, G., Frizzati, A., Harwood, J., Grozeva, D., GERAD/PERADES, consortia, I., Morgan, K., Passmore, P., et al. (2018) · PLoS ONE

Alzheimer's disease research and treatmentsGenetic Associations and Epidemiology

Cited by 31

Evaluation of clinical benefits of treatments for Alzheimer's disease

Liu, K. Y., Walsh, S., Brayne, C., Merrick, R., Richard, E., & Howard, R. (2023) · The Lancet Healthy Longevity

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 31

France removes state funding for dementia drugs

Walsh, S., King, E., & Brayne, C. (2019) · BMJ

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life

Cited by 25

Benefits of population-level interventions for dementia risk factors: an economic modelling study for England

Mukadam, N., Anderson, R., Walsh, S., Wittenberg, R., Knapp, M., Brayne, C., & Livingston, G. (2024) · The Lancet Healthy Longevity

Health Systems, Economic Evaluations, Quality of LifeDementia and Cognitive Impairment Research

Cited by 24

Extremes of baseline cognitive function determine the severity of delirium: a population study

Tsui, A., Yeo, N., Searle, S. D., Bowden, H., Hoffmann, K., Hornby, J., Goslett, A., Weston-Clarke, M., Lanham, D., Hogan, P., et al. (2023) · Brain

Intensive Care Unit Cognitive DisordersDementia and Cognitive Impairment Research

Cited by 22

What is a population-level approach to prevention, and how could we apply it to dementia risk reduction?

Walsh, S., Wallace, L., Mukadam, N., Mytton, O., Lafortune, L., Wills, W., & Brayne, C. (2023) · Public Health

Dementia and Cognitive Impairment ResearchPublic Health Policies and Education

Cited by 17

Polymorphisms in LMNA and near a SERPINA gene cluster are associated with cognitive function in older people

Cluett, C., Brayne, C., Clarke, R., Evans, G., Matthews, F., Rubinsztein, D. C., Huppert, F., Llewellyn, D. J., Rice, N., Henley, W., et al. (2010) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 12

Common bacterial infections and risk of incident cognitive decline or dementia: a systematic review protocol

Muzambi, R., Bhaskaran, K., Brayne, C., Smeeth, L., & Warren-Gash, C. (2019) · BMJ Open

Dementia and Cognitive Impairment ResearchBacterial Infections and Vaccines

Cited by 11

Sex Differences in Dementia, Cognition, and Health in the Cognitive Function and Ageing Studies (CFAS)

Merrick, R., & Brayne, C. (2024) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchSex and Gender in Healthcare

Cited by 10